Rheumatoid arthritis

Half of RA patients relapse after TNF inhibitor discontinuation

Almost half of patients with RA who discontinue TNF inhibitor treatment after achieving remission will relapse, a meta-analysis by Australian authors shows. A systematic review of 16 randomised controlled trials of elective discontinuation of TNFis in RA patients in remission  found an overall relapse rate of 47%. The duration of follow-up after withdrawal was over ...

Already a member?

Login to keep reading.

© 2021 the limbic